IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1022808
Abstract: Cancer vaccines exhibit specificity, effectiveness, and safety as an alternative immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid development of mRNA cancer vaccines in recent years. However, how to maintain long-term immune… read more here.
Keywords: development; cancer vaccines; promising adjuvant; memory ... See more keywords